社團法人中華民國學名藥協會
關於協會
ABOUT
活動與消息
NEWS
國際學名藥聯盟
IGBA
輔導諮詢
COUNSELING
藥品GDP專區
GDP
醫藥法規
LAWS
國際活動廣宣專區
International Event
網站連結
LINKS
聯絡我們
CONTACT
次選單
活動與消息
最新消息
研討會訊息
醫藥新聞
IGBA專區
LINKS
快速連結
學名藥手冊(民眾版)
學名藥手冊(專業版)
學名藥報乎你知(懶人包)
藥品GDP宣導折頁
藥品GDP宣導圖片
活動與消息
活動與消息
2026/10/20
[轉知] IGBA-Global Biosimilars Week 2026
IGBA -Global Biosimilars Week 2026 歡迎報名參加網路研討會 (2026/10/21 20:00~21:30)
Value of Global Access: The Benefits of Prioritizing Biosimilars
Wednesday 21 October
14:00-15:30 CEST / 08:00-09:30 EDT / 17:30-19:00 IST
(台灣時間 晚間 20:00~21:30)
Register for the webinar
International Generic and Biosimilar Medicines Association (IGBA) launch of Global Biosimilars Week 2026, running from 19-24 October, an online, international awareness campaign.
This year’s theme,
“Realizing the Global Value of Biosimilars,”
aims to expand understanding of the powerful and life-changing impact biosimilar medicines can have for patients, healthcare systems, economies and societies around the world.
During Global Biosimilars Week 2026, IGBA will bring together stakeholders from across healthcare, policy, industry and patient communities to share real-world experiences on social media, while exploring the future of biosimilar medicines.
Attend the official Global Biosimilars Week Webinar: Value of Global Access: The Benefits of Prioritizing Biosimilars on 21 October 2026, from 08:00–09:30 EDT / 14:00–15:30 CEST –
Register Here.
Moderated by the Association for Accessible Medicines Senior VP of Sciences and Regulatory Affairs, and IGBA Biosimilar Committee Co-Chair, Giuseppe Randazzo, and featuring panellists from diverse global regions, the Global Biosimilars Week 2026 webinar will showcase real-world case studies and robust conversation around how the prioritization of biosimilars will expand patient access, generate sustainable value and strengthen healthcare systems around the world.
Meet the speakers, published 8 October:
Engage with the post here
Website:
https://globalbiosimilarsweek.org/web/
Follow the IGBA LinkedIn:
igba-international-generic-and-biosimilars-association
回列表頁
TOP